{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:44:33Z","timestamp":1785350673189,"version":"3.55.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,1]]},"DOI":"10.1210\/jc.2013-4182","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T16:34:00Z","timestamp":1398270840000},"page":"E1183-E1190","source":"Crossref","is-referenced-by-count":48,"title":["Possible Targets for Nonimmunosuppressive Therapy of Graves' Orbitopathy"],"prefix":"10.1210","volume":"99","author":[{"given":"L.","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Molecular and Experimental Medicine (L.Z., F.G.-J., M.S.D., C.M.D., M.L.), United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Grennan-Jones","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Experimental Medicine (L.Z., F.G.-J., M.S.D., C.M.D., M.L.), United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Draman","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Experimental Medicine (L.Z., F.G.-J., M.S.D., C.M.D., M.L.), United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (C.L., D.M.), Cardiff and Vale University Health Board, Heath Park, Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (C.L., D.M.), Cardiff and Vale University Health Board, Heath Park, Cardiff CF14 4XN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Dayan","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Experimental Medicine (L.Z., F.G.-J., M.S.D., C.M.D., M.L.), United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Tee","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics (A.R.T.), Institute of Cancer and Genetics, School of Medicine, Cardiff University, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ludgate","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Experimental Medicine (L.Z., F.G.-J., M.S.D., C.M.D., M.L.), United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113351251300_B1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113351251300_B2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0029-1220935","article-title":"Current insights into the pathogenesis of Graves' orbitopathy","volume":"41","author":"Eckstein","year":"2009","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113351251300_B3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2249.2002.01792.x","article-title":"Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease","volume":"127","author":"Ludgate","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2019041113351251300_B4","first-page":"998","article-title":"Thyrotropin receptor expression in Graves' orbital adipose\/connective tissues: potential autoantigen in Graves' ophthalmopathy","volume":"83","author":"Bahn","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B5","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1210\/jcem.82.6.2003","article-title":"Thyrotropin receptor transcripts in human adipose tissue","volume":"82","author":"Crisp","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","article-title":"Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue","volume":"342","author":"Feliciello","year":"1993","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113351251300_B7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/thy.1999.9.1175","article-title":"The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy","volume":"9","author":"Khoo","year":"1999","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113351251300_B8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1210\/jc.2011-2890","article-title":"A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody","volume":"97","author":"Kumar","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JME-11-0006","article-title":"A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy","volume":"46","author":"Kumar","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041113351251300_B10","doi-asserted-by":"crossref","first-page":"26447","DOI":"10.1074\/jbc.M109.003616","article-title":"Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113351251300_B11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/jc.2011-1299","article-title":"Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/en.2005-1375","article-title":"Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease","volume":"147","author":"Gianoukakis","year":"2006","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113351251300_B13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jc.2012-1771","article-title":"Autoantibodies to the IGF1 receptor in Graves' orbitopathy","volume":"98","author":"Minich","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916939309014643","article-title":"Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy","volume":"16","author":"Weightman","year":"1993","journal-title":"Autoimmunity"},{"key":"key\n\t\t\t\t2019041113351251300_B15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/jc.2012-2270","article-title":"Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathy","volume":"98","author":"Varewijck","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(86)90698-7","article-title":"Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin","volume":"1","author":"Hansson","year":"1986","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113351251300_B17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2002-021349","article-title":"Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease","volume":"88","author":"Krassas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t2019041113351251300_B18","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jc.2011-0307","article-title":"Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?","volume":"96","author":"Wiersinga","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B19","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1167\/iovs.06-0596","article-title":"Biological effects of thyrotropin receptor activation on human orbital preadipocytes","volume":"47","author":"Zhang","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key\n\t\t\t\t2019041113351251300_B20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11910-012-0256-9","article-title":"Thyroid eye disease: towards an evidence base for treatment in the 21st century","volume":"12","author":"Gillespie","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key\n\t\t\t\t2019041113351251300_B21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","article-title":"Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study","volume":"156","author":"Salvi","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113351251300_B22","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113351251300_B23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/oby.2000.29","article-title":"Rapamycin inhibits human adipocyte differentiation in primary culture","volume":"8","author":"Bell","year":"2000","journal-title":"Obes Res"},{"key":"key\n\t\t\t\t2019041113351251300_B24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as drug target in human cancer","volume":"28","author":"Courtney","year":"2010","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113351251300_B25","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)","volume":"269","author":"Vlahos","year":"1994","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113351251300_B26","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1210\/jc.2003-031682","article-title":"Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes","volume":"89","author":"Scavo","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B27","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B28","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019041113351251300_B29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of thyrotropin receptor antibody-induced signaling cascades","volume":"150","author":"Morshed","year":"2009","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113351251300_B30","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(92)90024-Z","article-title":"Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor","volume":"88","author":"Van Sande","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t2019041113351251300_B31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/JOE-09-0099","article-title":"Gsalpha signalling suppresses PPAR\u03b32 generation and inhibits 3T3-L1 adipogenesis","volume":"202","author":"Zhang","year":"2009","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t2019041113351251300_B32","doi-asserted-by":"crossref","first-page":"28945","DOI":"10.1074\/jbc.273.44.28945","article-title":"Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase","volume":"273","author":"Sakaue","year":"1998","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113351251300_B33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-007-9661-9","article-title":"Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells","volume":"310","author":"Yu","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"key\n\t\t\t\t2019041113351251300_B34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.lfs.2006.09.029","article-title":"H-89 potentiates adipogenesis in 3T3-L1 cells by activating insulin signaling independently of protein kinase A","volume":"80","author":"Kato","year":"2007","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t2019041113351251300_B35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/cr.2008.12","article-title":"Protein kinase A suppresses the differentiation of 3T3-L1 preadipocytes","volume":"18","author":"Li","year":"2008","journal-title":"Cell Research"},{"key":"key\n\t\t\t\t2019041113351251300_B36","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1210\/jc.2013-1149","article-title":"A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy","volume":"98","author":"Turcu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1677\/jme.0.0300369","article-title":"Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo","volume":"30","author":"Starkey","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041113351251300_B38","first-page":"2557","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor","volume":"84","author":"Valyasevi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113351251300_B39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0974-9233.92115","article-title":"The past, present, and future of exudative age-related macular degeneration treatment","volume":"19","author":"Barak","year":"2012","journal-title":"Middle East Afr J Ophthalmol"},{"key":"key\n\t\t\t\t2019041113351251300_B40","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1158\/0008-5472.CAN-08-2058","article-title":"Palomid 529, a novel small-molecule drug, is a TORC1\/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability","volume":"68","author":"Xue","year":"2008","journal-title":"Cancer Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/7\/E1183\/17637885\/jcem1183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:59:58Z","timestamp":1648875598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/7\/E1183\/2537358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-4182","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}